Current Drug Metabolism
Title:Editorial: [Hot Topics: Metabolism and Drug-Drug Interaction Potential of Biotherapeutics]
Volume: 13 Issue: 7
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
P. Li Albert, Editorial: [Hot Topics: Metabolism and Drug-Drug Interaction Potential of Biotherapeutics], Current Drug Metabolism 2012; 13 (7) . https://dx.doi.org/10.2174/138920012802138697
DOI https://dx.doi.org/10.2174/138920012802138697 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Polymorphisms in the Growth Hormone Receptor: Impact on Growth Response and Disease Susceptibility
Current Pharmacogenomics and Personalized Medicine The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Chemistry of the Genus Dorstenia
Current Organic Chemistry Recent Clinical Trials in Non-Small Cell Lung Cancer
Current Cancer Therapy Reviews 7-prenyloxi-6-methoxycoumarin from Polygala sabulosa A.W. Bennett Regulates p38 MAPK and NF-kB Pathways Inhibiting the Inflammation Induced by Carrageenan in the Mouse Model of Pleurisy
Inflammation & Allergy - Drug Targets (Discontinued) Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges
Current Medicinal Chemistry Review and Analysis of Massively Registered Clinical Trials of COVID-19 using the Text Mining Approach
Reviews on Recent Clinical Trials Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
Current Drug Targets Editorial (Thematic Issue: Neovascularization in Hematological Malignancies: Biologic and Clinical Implications)
Current Angiogenesis (Discontinued) Opioids in Neuropathic Pain
Current Pharmaceutical Design RNA Interference and Potential Applications
Current Topics in Medicinal Chemistry Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies
Current Drug Targets Reproduction in Couples with Chronic Viral Infections
Current Women`s Health Reviews Is Ecto-nucleoside Triphosphate Diphosphohydrolase (NTPDase)-based Therapy of Central Nervous System Disorders Possible?
Mini-Reviews in Medicinal Chemistry Nanotechnology Enabled Drug Delivery Systems for Bone and Cartilage Regeneration
Recent Patents on Biomedical Engineering (Discontinued) β-arrestin-Biased Agonism at the Parathyroid Hormone Receptor Uncouples Bone Formation from Bone Resorption
Endocrine, Metabolic & Immune Disorders - Drug Targets Idronoxil as an Anticancer Agent: Activity and Mechanisms
Current Cancer Drug Targets The Neonatal Immune System: General Concepts and Clinical Correlations
Current Immunology Reviews (Discontinued) Hypothalamic Leptin and Ghrelin Signaling as Targets for Improvement in Metabolic Control
Current Pharmaceutical Design Macrophage Activation and HIV Infection: Can the Trojan Horse Turn into a Fortress?
Current Molecular Medicine